Intercellular interaction of PD-L1 on cancer cells with PD-1 on immune cells triggers tyrosine phosphorylation of the PD-1 cytoplasmic domain, resulting in reduced phosphorylation of TCR signaling molecules and inhibition of T cell activation and cytokine production (1). Here, CD274 is linked to cancer.